drugset

drugset / Trial / NCT02665728

A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adolescent Subjects

NCT02665728 ↗

Phase 2 Completed 33 enrolled Braintree Laboratories

NaSingle-groupOpen-labelTreatment

Summary

The objective of this study is to evaluate the safety and efficacy of BLI400 laxative in constipated adolescent subjects.

Timeline

Start: 2015-12
Primary completion: 2016-04
Completion: 2016-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Lactitol	Small molecule	—	—

Indications